Advertisement
Review article| Volume 73, ISSUE 2, P154-165, February 2006

Download started.

Ok

Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review

  • Anshu P. Mohllajee
    Affiliations
    Centers for Disease Control and Prevention, Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Atlanta, GA 30341, USA
    Search for articles by this author
  • Kathryn M. Curtis
    Correspondence
    Corresponding author. Tel.: +1 770 488 6397; fax: +1 770 488 6391.
    Affiliations
    Centers for Disease Control and Prevention, Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Atlanta, GA 30341, USA
    Search for articles by this author
  • Summer L. Martins
    Affiliations
    Centers for Disease Control and Prevention, Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Atlanta, GA 30341, USA
    Search for articles by this author
  • Herbert B. Peterson
    Affiliations
    Department of Maternal and Child Health, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Search for articles by this author

      Abstract

      Previous research has suggested that hormonal contraceptive users, compared with nonusers, may be at increased risk for acquiring sexually transmitted infections (STIs). We searched the MEDLINE and EMBASE databases for all articles from January 1966 through February 2005 for evidence relevant to all hormonal contraceptives and STIs (including cervical chlamydial and gonococcal infection, human papillomavirus, trichomoniasis, herpes and syphilis). We used standard abstract forms and grading systems to summarize and assess the quality of 83 identified studies. Studies of combined oral contraceptive and depot medroxyprogesterone use generally reported positive associations with cervical chlamydial infection, although not all associations were statistically significant. For other STIs, the findings suggested no association between hormonal contraceptive use and STI acquisition, or the results were too limited to draw any conclusions. Evidence was generally limited in both amount and quality, including inadequate adjustment for confounding, lack of appropriate control groups and small sample sizes. The observed positive associations may be due to a true association or to bias, such as differential exposure to STIs by contraceptive use or increased likelihood of STI detection among hormonal contraceptive users.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        WHO global prevalence and incidence of selected curable sexually transmitted infections overview and estimates.
        WHO, Geneva2005
      1. United Nations. World Contraceptive Use, 2003. Accessed March 29, 2005 at http://www.un.org/esa/population/publications/contraceptive2003/WCU2003.htm.

        • Critchlow C.W.
        • Wolner-Hanssen P.
        • Eschenbach D.A.
        • et al.
        Determinants of cervical ectopia and of cervicitis; age, oral contraception, specific cervical infection, smoking, and douching.
        Am J Obstet Gynecol. 1995; 173: 534-543
        • Harrison H.R.
        • Costin M.
        • Meder J.B.
        • et al.
        Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis.
        Am J Obstet Gynecol. 1985; 153: 244-251
        • Louv W.C.
        • Austin H.
        • Perlman J.
        • Alexander W.J.
        Oral contraceptive use and the risk of chlamydial and gonococcal infections.
        Am J Obstet Gynecol. 1989; 160: 396-402
        • Rahm V.A.
        • Odlind V.
        • Pettersson R.
        Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infection: a prospective study.
        Genitourin Med. 1991; 67: 317-321
        • Toon P.G.
        • Arrand J.R.
        • Wilson L.P.
        • Sharp D.S.
        Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.
        BMJ. 1986; 293: 1261-1264
        • Plourde P.J.
        • Pepin J.
        • Agoki E.
        • et al.
        Human immunodeficiency virus type 1 seroconversion in women with genital ulcers.
        J Infect Dis. 1994; 170: 313-317
        • Chacko M.
        • Lovchik J.
        Chlamydia trachomatis infection in sexually active adolescents: prevalence and risk factors.
        Pediatrics. 1984; 73: 836-840
        • Morrison C.S.
        • Bright P.
        • Wong E.L.
        • et al.
        Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections.
        Sex Transm Dis. 2004; 31: 561-567
        • Cottingham J.
        • Hunter D.
        Chlamydia trachomatis and oral contraceptive use: a quantitative review.
        Genitourin Med. 1992; 68: 209-216
        • Nayyar K.C.
        • O'Neill J.J.
        • Hambling M.H.
        • Waugh M.A.
        Isolation of Chlamydia trachomatis from women attending a clinic for sexually transmitted diseases.
        Br J Vener Dis. 1976; 52: 396-398
        • Oh M.K.
        • Feinstein R.A.
        • Soileau E.J.
        • Cloud G.A.
        • Pass R.F.
        Chlamydia trachomatis cervical infection and oral contraceptive use among adolescent girls.
        J Adolesc Health Care. 1989; 10: 376-381
        • Acosta-Cazares B.
        • Ruiz-Maya L.
        • Escobedo de la Pena J.
        Prevalence and risk factors for Chlamydia trachomatis infection in low-income rural and suburban populations of Mexico.
        Sex Transm Dis. 1996; 23: 283-288
        • Addiss D.G.
        • Vaughn M.L.
        • Holzhueter M.A.
        • Bakken L.L.
        • Davis J.P.
        Selective screening for Chlamydia trachomatis infection in nonurban family planning clinics in Wisconsin.
        Fam Plann Perspect. 1987; 19: 252-256
        • Arya O.P.
        • Mallinson H.
        • Goddard A.D.
        Epidemiological and clinical correlates of chlamydial infection of the cervix.
        Br J Vener Dis. 1981; 57: 118-124
        • Barnes R.C.
        • Katz B.P.
        • Rolfs R.T.
        • Batteiger B.
        • Caine V.
        • Jones R.B.
        Quantitative culture of endocervical Chlamydia trachomatis.
        J Clin Microbiol. 1990; 28: 774-780
        • Blum M.
        • Pery J.
        • Kitai E.
        The link between contraceptive methods and Chlamydia trachomatis infection.
        Adv Contracept. 1988; 4: 233-239
        • Bontis J.
        • Vavilis D.
        • Panidis D.
        • Theodoridis T.
        • Konstantinidis T.
        • Sidiropoulou A.
        Detection of Chlamydia trachomatis in asymptomatic women: relationship to history, contraception, and cervicitis.
        Adv Contracept. 1994; 10: 309-315
        • Bro F.
        • Juul S.
        Predictors of Chlamydia trachomatis infection in women in general practice.
        Fam Pract. 1990; 7: 138-143
        • Burns D.C.
        • Darougar S.
        • Thin R.N.
        • Lothian L.
        • Nicol C.S.
        Isolation of chlamydia from women attending a clinic for sexually transmitted disease.
        Br J Vener Dis. 1975; 51: 314-318
        • Crowley T.
        • Horner P.
        • Hughes A.
        • Berry J.
        • Paul I.
        • Caul O.
        Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?.
        Int J STD AIDS. 1997; 8: 25-31
        • Edwards D.
        • Phillips D.
        • Stancombe S.
        Chlamydia trachomatis infection at a family planning clinic.
        N Z Med J. 1985; 98: 333-335
        • Evans D.L.
        • Demetriou E.
        • Shalaby H.
        • Waner J.L.
        Detection of Chlamydia trachomatis in adolescent females using direct immunofluorescence.
        Clin Pediatr. 1988; 27: 223-228
        • Fish A.N.
        • Fairweather D.V.
        • Oriel J.D.
        • Ridgway G.L.
        Chlamydia trachomatis infection in a gynaecology clinic population: identification of high-risk groups and the value of contact tracing.
        Eur J Obstet Gynecol Reprod Biol. 1989; 31: 67-74
        • Fraser J.J.
        • Rettig P.J.
        • Kaplan D.W.
        Prevalence of cervical Chlamydia trachomatis and Neisseria gonorrhoeae in female adolescents.
        Pediatrics. 1983; 71: 333-336
        • Han Y.
        • Morse D.L.
        • Lawrence C.E.
        • Murphy D.
        • Hipp S.
        Risk profile for chlamydia infection in women from public health clinics in New York State.
        J Community Health. 1993; 18: 1-9
        • Handsfield H.H.
        • Jasman L.L.
        • Roberts P.L.
        • Hanson V.W.
        • Kothenbeutel R.L.
        • Stamm W.E.
        Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics.
        JAMA. 1986; 255: 1730-1734
        • Hanna N.F.
        • Taylor-Robinson D.
        • Kalodiki-Karamanoli M.
        • Harris J.R.
        • McFadyen I.R.
        The relation between vaginal pH and the microbiological status in vaginitis.
        Br J Obstet Gynaecol. 1985; 92: 1267-1271
        • Hart G.
        Factors associated with genital chlamydial and gonococcal infection in females.
        Genitourin Med. 1992; 68: 217-220
        • Herrmann B.
        • Espinoza F.
        • Villegas R.R.
        • Smith G.D.
        • Ramos A.
        • Egger M.
        Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations.
        Genitourin Med. 1996; 72: 20-26
        • Hilton A.L.
        • Richmond S.J.
        • Milne J.D.
        • Hindley F.
        • Clarke S.K.
        Chlamydia A in the female genital tract.
        Br J Vener Dis. 1974; 50: 1-10
        • Hiltunen-Back E.
        • Haikala O.
        • Kautiainen H.
        • Paavonen J.
        • Reunala T.
        A nationwide sentinel clinic survey of Chlamydia trachomatis infection in Finland.
        Sex Transm Dis. 2001; 28: 252-258
        • The Italian MEGIC Group
        Determinants of cervical Chlamydia trachomatis infection in Italy.
        Genitourin Med. 1993; 69: 123-125
        • Jacobson D.L.
        • Peralta L.
        • Farmer M.
        • Graham N.M.
        • Gaydos C.
        • Zenilman J.
        Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents.
        Sex Transm Dis. 2000; 27: 313-319
        • Jaffe L.R.
        • Siqueira L.M.
        • Diamond S.B.
        • Diaz A.
        • Spielsinger N.A.
        Chlamydia trachomatis detection in adolescents: a comparison of direct specimen and tissue culture methods.
        J Adolesc Health Care. 1986; 7: 401-404
        • Kinghorn G.R.
        • Waugh M.A.
        Oral contraceptive use and prevalence of infection with Chlamydia trachomatis in women.
        Br J Vener Dis. 1981; 57: 187-190
        • Lefevre J.C.
        • Averous S.
        • Bauriaud R.
        • Blanc C.
        • Bertrand M.A.
        • Lareng M.B.
        Lower genital tract infections in women: comparison of clinical and epidemiologic findings with microbiology.
        Sex Transm Dis. 1988; 15: 110-113
        • Lycke E.
        • Lowhagen G.B.
        • Hallhagen G.
        • Johannisson G.
        • Ramstedt K.
        The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection.
        Sex Transm Dis. 1980; 7: 6-10
        • Macaulay M.E.
        • Riordan T.
        • James J.M.
        • et al.
        A prospective study of genital infections in a family-planning clinic. 2. Chlamydia infection���the identification of a high-risk group.
        Epidemiol Infect. 1990; 104: 55-61
        • Magder L.S.
        • Klontz K.C.
        • Bush L.H.
        • Barnes R.C.
        Effect of patient characteristics on performance of an enzyme immunoassay for detecting cervical Chlamydia trachomatis infection.
        J Clin Microbiol. 1990; 28: 781-784
        • Magder L.S.
        • Harrison H.R.
        • Ehret J.M.
        • Anderson T.S.
        • Judson F.N.
        Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic.
        Am J Epidemiol. 1988; 128: 298-308
        • Masse R.
        • Laperriere H.
        • Rousseau H.
        • Lefebvre J.
        • Remis R.S.
        Chlamydia trachomatis cervical infection: prevalence and determinants among women presenting for routine gynecologic examination.
        CMAJ. 1991; 145: 953-961
        • Oriel J.D.
        • Johnson A.L.
        • Barlow D.
        • Thomas B.J.
        • Nayyar K.
        • Reeve P.
        Infection of the uterine cervix with Chlamydia trachomatis.
        J Infect Dis. 1978; 137: 443-451
        • Paavonen J.
        • Vesterinen E.
        Chlamydia trachomatis in cervicitis and urethritis in women.
        Scand J Infect Dis Suppl. 1982; 32: 45-54
        • Park B.J.
        • Stergachis A.
        • Scholes D.
        • Heidrich F.E.
        • Holmes K.K.
        • Stamm W.E.
        Contraceptive methods and the risk of Chlamydia trachomatis infection in young women.
        Am J Epidemiol. 1995; 142: 771-778
        • Pereira L.H.
        • Embil J.A.
        • Haase D.A.
        • Manley K.M.
        Cytomegalovirus infection among women attending a sexually transmitted disease clinic: association with clinical symptoms and other sexually transmitted diseases.
        Am J Epidemiol. 1990; 131: 683-692
        • Ripa K.T.
        • Svensson L.
        • Mardh P.A.
        • Westrom L.
        Chlamydia trachomatis cervicitis in gynecologic outpatients.
        Obstet Gynecol. 1978; 52: 698-702
        • Ruijs G.J.
        • Kauer F.M.
        • van Gijssel P.M.
        • Schirm J.
        • Schroder F.P.
        Direct immunofluorescence for Chlamydia trachomatis on urogenital smears for epidemiological purposes.
        Eur J Obstet Gynecol Reprod Biol. 1988; 27: 289-297
        • Schachter J.
        • Stoner E.
        • Moncada J.
        Screening for chlamydial infections in women attending family planning clinics.
        West J Med. 1983; 138: 375-379
        • Sessa R.
        • Latino M.A.
        • Magliano E.M.
        • et al.
        Epidemiology of urogenital infections caused by Chlamydia trachomatis and outline of characteristic features of patients at risk.
        J Med Microbiol. 1994; 41: 168-172
        • Shafer M.A.
        • Beck A.
        • Blain B.
        • et al.
        Chlamydia trachomatis: important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear.
        J Pediatr. 1984; 104: 141-146
        • Staerfelt F.
        • Gundersen T.J.
        • Halsos A.M.
        • et al.
        A survey of genital infections in patients attending a clinic for sexually transmitted diseases.
        Scand J Infect Dis Suppl. 1983; 40: 53-57
        • Svensson L.
        • Westrom L.
        • Mardh P.A.
        Chlamydia trachomatis in women attending a gynaecological outpatient clinic with lower genital tract infection.
        Br J Vener Dis. 1981; 57: 259-262
        • Tait I.A.
        • Rees E.
        • Hobson D.
        • Byng R.E.
        • Tweedie M.C.
        Chlamydial infection of the cervix in contacts of men with nongonococcal urethritis.
        Br J Vener Dis. 1980; 56: 37-45
        • Winter L.
        • Goldy A.S.
        • Baer C.
        Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations.
        Sex Transm Dis. 1990; 17: 30-36
        • Woolfitt J.M.
        • Watt L.
        Chlamydial infection of the urogenital tract in promiscuous and non-promiscuous women.
        Br J Vener Dis. 1977; 53: 93-95
        • Oriel J.D.
        • Powis P.A.
        • Reeve P.
        • Miller A.
        • Nicol C.S.
        Chlamydial infections of the cervix.
        Br J Vener Dis. 1974; 50: 11-16
        • Avonts D.
        • Sercu M.
        • Heyerick P.
        • Vandermeeren I.
        • Meheus A.
        • Piot P.
        Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study.
        Sex Transm Dis. 1990; 17: 23-29
        • Baeten J.M.
        • Nyange P.M.
        • Richardson B.A.
        • et al.
        Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
        Am J Obstet Gynecol. 2001; 185: 380-385
        • Lavreys L.
        • Chohan V.
        • Overbaugh J.
        • et al.
        Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women.
        AIDS. 2004; 18: 2179-2184
        • Austin H.
        • Louv W.C.
        • Alexander W.J.
        A case-control study of spermicides and gonorrhea.
        JAMA. 1984; 251: 2822-2824
        • Jick H.
        • Hannan M.T.
        • Stergachis A.
        • Heidrich F.
        • Perera D.R.
        • Rothman K.J.
        Vaginal spermicides and gonorrhea.
        JAMA. 1982; 248: 1619-1621
        • Keith L.
        • Berer G.S.
        • Moss W.
        Cervical gonorrhea in women using different methods of contraception.
        J Am Vener Dis Assoc. 1976; 3: 17-19
        • Berger G.S.
        • Keith L.
        • Moss W.
        Prevalence of gonorrhoea among women using various methods of contraception.
        Br J Vener Dis. 1975; 51: 307-309
        • Lowe T.L.
        • Kraus S.J.
        Quantitation of Neisseria gonorrhoeae from women with gonorrhea.
        J Infect Dis. 1976; 133: 621-626
        • McCormack W.M.
        • Reynolds G.H.
        • Cooperative Study Group
        Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae.
        JAMA. 1982; 247: 1292-1294
        • Bramley M.
        • Kinghorn G.
        Do oral contraceptives inhibit Trichomonas vaginalis?.
        Sex Transm Dis. 1979; 6: 261-263
        • Johannisson G.
        • Karamustafa A.
        • Brorson J.
        Influence of copper salts on gonococci.
        Br J Vener Dis. 1976; 52: 176-177
        • Griffiths M.
        • Hindley D.
        Gonococcal pelvic inflammatory disease, oral contraceptives, and cervical mucus.
        Genitourin Med. 1985; 61: 67
        • Bhattacharyya M.N.
        • Jephcott A.E.
        Diagnosis of gonorrhea in women ��� influence of the contraceptive pill.
        J Am Vener Dis Assoc. 1976; 2: 21-24
        • Hewitt A.B.
        Oral contraception among special clinic patients with particular reference to the diagnosis of gonorrhoea.
        Br J Vener Dis. 1970; 46: 106-107
        • Gertig D.M.
        • Kapiga S.H.
        • Shao J.F.
        • Hunter D.J.
        Risk factors for sexually transmitted diseases among women attending family planning clinics in Dar-es-Salaam, Tanzania.
        Genitourin Med. 1997; 73: 39-43
        • Green J.
        • de Gonzalez A.B.
        • Smith J.S.
        • et al.
        Human papillomavirus infection and use of oral contraceptives.
        Br J Cancer. 2003; 88: 1713-1720
        • Winer R.L.
        • Lee S.K.
        • Hughes J.P.
        • Adam D.E.
        • Kiviat N.B.
        • Koutsky L.A.
        Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.
        Am J Epidemiol. 2003; 157: 218-226
        • Sellors J.W.
        • Karwalajtys T.L.
        • Kaczorowski J.
        • et al.
        Incidence, clearance and predictors of human papillomavirus infection in women.
        CMAJ. 2003; 168: 421-425
        • Moscicki A.B.
        • Hills N.
        • Shiboski S.
        • et al.
        Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.
        JAMA. 2001; 285: 2995-3002
        • Giuliano A.R.
        • Papenfuss M.
        • Abrahamsen M.
        • et al.
        Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
        Cancer Epidemiol Biomarkers Prev. 2001; 10: 1129-1136
        • Lavreys L.
        • Chohan B.
        • Ashley R.
        • et al.
        Human herpes virus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya.
        J Infect Dis. 2003; 187: 359-363
        • Smith J.S.
        • Herrero R.
        • Munoz N.
        • et al.
        Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines.
        Sex Transm Dis. 2001; 28: 187-194
        • Willmott F.E.
        • Mair H.J.
        Genital herpes virus infection in women attending a venereal diseases clinic.
        Br J Vener Dis. 1978; 54: 341-343
        • Evans B.A.
        • Kell P.D.
        • Bond R.A.
        • MacRae K.D.
        • Slomka M.J.
        • Brown D.W.
        Predictors of seropositivity to herpes simplex virus type 2 in women.
        Int J STD AIDS. 2003; 14: 30-36
        • Wolinska W.H.
        • Melamed M.R.
        Herpes genitalis in women attending planned parenthood of New York City.
        Acta Cytol. 1970; 14: 239-242
        • Ackers J.P.
        • Lumsden W.H.
        • Catterall R.D.
        • Coyle R.
        Antitrichomonal antibody in the vaginal secretions of women infected with T. vaginalis.
        Br J Vener Dis. 1975; 51: 319-323
        • Ceruti M.
        • Canestrelli M.
        • Condemi V.
        • et al.
        Methods of contraception and rates of genital infections.
        Clin Exp Obstet Gynecol. 1994; 21: 119-123
        • Fouts A.C.
        • Kraus S.J.
        Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis.
        J Infect Dis. 1980; 141: 137-143
        • Reed B.D.
        • Huck W.
        • Zazove P.
        Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina.
        J Fam Pract. 1989; 28: 673-680
        • Barbone F.
        • Austin H.
        • Louv W.C.
        • Alexander W.J.
        A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis.
        Am J Obstet Gynecol. 1990; 163: 510-514
        • Mohllajee A.P.
        • Curtis K.M.
        • Flanagan R.G.
        • Rinehart W.
        • Gaffield M.
        • Peterson H.B.
        Keeping up with evidence: a new system for WHO's evidence-based family planning guidance.
        Am J Prev Med. 2005; 28: 483-490
        • Harris R.P.
        • Helfand M.
        • Woolf S.H.
        • et al.
        Current methods of the US Preventive Services Task Force: a review of the process.
        Am J Prev Med. 2001; 20: 21-35
        • Nsofor B.I.
        • Bello C.S.
        • Ekwempu C.C.
        Sexually transmitted disease among women attending a family planning clinic in Zaria, Nigeria.
        Int J Gynaecol Obstet. 1989; 28: 365-367
        • Rahm V.A.
        • Odlind V.
        • Gnarpe H.
        Chlamydia trachomatis among sexually active teenage girls: influence of sampling location and clinical signs on the detection rate.
        Genitourin Med. 1990; 66: 66-69
        • World Health Organization
        Medical eligibility for contraceptive use.
        3rd ed. World Health Organization, Geneva2004